Clinical Trial Update: Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth Factor [NA]

View source ↗

Summary

Clinical trial evaluating ridge augmentation using allograft particles with or without recombinant human platelet-derived growth factor; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Loss

Drugs mentioned

• recombinant human platelet-derived growth factor (recombinant human PDGF-BB)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Dental Implant, Bone Loss | NA | Status: RECRUITING